Diseases List

ID 63
Name HYPERTHYROIDISM
Cause
Signs Symptoms
Diagnosis Diagnosis: 1. Serum T3 & T4 estimation- usually elevated. TSH- reduced or unrecordable. 2. Protein bound iodine is increased. 3. Radioactive iodine uptake is increased. 4. TRHtest. 5. Serum cholesterol is decreased. 6. E.C.G shows different types of arrythmias. 7. Thyroid scanning.
Investigations
Management Management of Ophthalmopathy: 1. Reassurance 2. Methylcellulose eye drops- counter the gritty discomfort of dry eyes. 3. To reduce excessive lacrimation due to exce-ssive stimulation by sun & wind- tinted glasses or side shield attached spectacle can be used. 4. If corneal ulceration- lateral tersorrhaphy is done 5. If persistant diplopia- extraoccular muscle surgery is done. 6. If papilloedema, visual field defect or loss of visual field then treatment with prednisolone 60mg/day. If no significant improvement with 7-10 day therapy then orbital decompression is done. Management of Dermopathy: Pretibial myxoedema rarely requires treatment. If required- local injection of triamcinolone acetate or application of betamethasone ointment under occlusive dressings may be effective.
Introduction Hyperthyroidism is the clinical syndrome which results from exposure of the body tissue to excess circulating levels of free thyroid hormones. Females are more affected than males. Grave’s disease is distinguished clinically from other forms of hyperthyroidism by the presence of diffuse thyroid enlargement, ophthalmopathy and rarely pretibial myxoedema.
History
Etiology
Clinical Features Clinical features: Goitre- Diffuse ± bruit, nodular. Gastrointestinal- Weight loss despite normal or increased appetite, hyperdefaecation, diarrhoea and steatorrhoea, anorexia, vomiting. Cardiorespiratory- Palpitations, sinus tachycardia, atrial fibrillation, increased pulse pressure, ankle oedema in absence of cardiac failure, angina, cardiomyopathy & cardiac failure, dyspnoea on exertion, exacerbation of asthma. Neuromuscular- Nervousness, irritability, emotional lability, psychosis, tremor, hyper-reflexia, ill-sustained clonus, muscle weakness, proximal myopathy, bulbar myopathy, periodic paralysis. Dermatological- Increased sweating, pruritus, palmar erythema, spider naevi, onycholysis, alopecia, pigmentation, vitiligo, finger clubbing, pretibial myxoedema. Reproducitve- Amenorrhoea/oligomenorrhoea, infertility, spontaneous abortion, loss of libido, impotence. Ocular- Lid retraction, lid lag, grittiness, excessive lacrimation, chemosis, exophthalmos, corneal ulceration, ophthalmoplegia, diplopia, papilloedema, loss of visual acuity. Other- Heat intolerance, fatigue, apathy, gynaecomastia, lympha-denopathy, thirst.
Preventions
Treatment Treatments: The treatment of hyperthyroidism (thyrotoxicosis) depends on the underlying cause and may include antithyroid drugs, radioactive iodine therapy or surgery (subtotal thyroidectomy). A. Anthithyroid drugs (e.g Carbimazole): Indications- 1st episode in patients < 40 years. Contraindications- hypersensitivity, breast feeding Disadvantages/complications- > 50% relapse rate usually within 2 years of stopping drug. Carbimazole dosage: 0-3 weeks - 15mg 3 times daily 4-8 weeks - 10mg 3 times daily Maintenance - 5-20mg daily Duration of treatment- 18-24 months. B. Subtotal thyroidectomy: Indications - 1. Recurrent hyperthyroidism after course of antithyroid drugs in patients <40yrs. 2. Initial treatment in males with large goitres and in those with severe hyperthyroidism i.e total T3, > 9.0 nmol/1. 3. Poor drug compliance. Contraindication - Previous thyroid surgery, dependence upon voice e.g opera singer, lectuer. Disadvantages/complications - Transient hypocalcaemia (10%), Hypopara-thyroidism (1%), recurrent laryngeal nerve palsy (1%). C. Radioiodine: Indications - 1. Patients > 40 years. 2. Recurrence following surgery irrespective of age. 3. Other serious illness e.g multiple sclerosis irrespective of age. Contraindications- Pregnancy or planned pregnancy within 6 months of treatment. Disadvantages/complications- Hypothyroidism, approximately 40% in 1st year, 80% after 15 years. D. Beta-adrenoceptor antagonists: Beta-adrenoceptor antagonist such as propranolol 160mg daily (40mg 6-hourly) or nadolol 40-80mg daily may be given. Some of the toxic manifestations of thyrotoxicosis are most rapidly (within 24-48 hours) reversed by this drug but can not be recommended for long term treatment.
Complications
Prognosis
Types
Classification
Observation
Pathology
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406